Acarix AB (publ) (ACARIX.ST)
Acarix AB (publ) operates in the Medical - Devices industry of the Healthcare sector, headquartered in Malmö, SN, SE. The stock last traded at $0.20, up 2.55% on the session, giving a market capitalisation of $225.8M. Its beta of -0.21 implies it has historically moved less than the broad market.
Acarix AB (publ) is a medical technology company that develops and introduces diagnostic solutions for cardiovascular conditions to markets including Germany, Sweden, the Middle East, Switzerland, Austria, and globally. Their key product is the CADScor System, an exceptionally sensitive, non-invasive analytical device designed for the detection of coronary artery disease. Founded in 2009, Acarix AB (publ) maintains its headquarters in Malmö, Sweden.
Acarix AB (publ) is most often compared with the following Healthcare names: